SEC Form D · filed December 23, 2019
KEMPHARM, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Timothy J. Sangiovanni · Celebration, FLExecTravis C. Mickle · Celebration, FLExec · Director · PromoterR. L. Clifton · Celebration, FLExecJoseph B. Saluri · Celebration, FLDirectorMatthew R. Plooster · Celebration, FLDirectorSven L. Guenther · Celebration, FLExecRichard W. Pascoe · Celebration, FLDirectorGordon K. Johnson · Celebration, FLExecDavid S. Tierney · Celebration, FLDirectorTodd Hixon · Reston, VAExecStuart N. Ballard · London, United KingdomDirectorKenneth D. Cron · New York, NYExecCormac Sheehan · New York, NYDirectorSims Lansing · New York, NYDirectorKatherine Lewis · Las Vegas, NVDirectorStephen Sarsfield · Las Vegas, NVExecScott Johnson · Reston, VAExec · Director · PromoterJonathan Roney · New York, NYExecAngela P. Ciampa · BOSTON, MADirectorScott B. Garfield · BOSTON, MADirectorVipon B. Ghai · BOSTON, MAExecScott B. Mcfetridge · BOSTON, MAExecBrian R. Albert · BOSTON, MAExec · Director · PromoterPaul A. Fishbin · BOSTON, MADirectorJoshua A. Liebow · BOSTON, MADirectorMateusz A. Szwarc · BOSTON, MAExecAdrienne Lerner · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗